Praxis Precision Medicines, Inc. Announces Pricing of $59.1

BOSTON, June 15, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...

Related Keywords

Boston ,Massachusetts ,United States ,Piper Sandler ,Praxis Precision Medicines Inc ,Prospectus Department ,Exchange Commission ,Nasdaq ,Piper Sandler Co ,Truist Securities Inc ,Precision Medicines ,Truist Securities ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Although Praxi ,